Promaxo

company

About

Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician's office.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$2.20M
Industries
Health Care,Health Diagnostics,Medical Device,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Promaxo is a medical technology company that develops and commercializes customer-centric MRI systems, and MRI compatible robotics and machine learning based technologies that enhance patients' lives and redefine the standard of care. Using proprietary technologies protected by 55+ patents, the Company is bringing the first MRI and robotics guidance system for in-office use. Products in the pipeline include disposables and an AI-based tissue characterization system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$13.17M
Promaxo has raised a total of $13.17M in funding over 2 rounds. Their latest funding was raised on May 28, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 28, 2020 Series B $10.97M 1 Kineticos Disruptor Fund Detail
Apr 11, 2018 Series A $2.20M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Promaxo is funded by 3 investors. Kineticos Disruptor Fund and RocSon Medtech Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Kineticos Disruptor Fund Yes Series B
RocSon Medtech Fund Series A
Almond Tree Capital Fund Series A